Sivik Global Healthcare’s NEVRO CORP. NVRO Stock Holding History

Sivik Global Healthcare’s Portfolio NVRO Stock Details NVRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-40,000	Closed	-$4.78M	–	60
2020 Q2	$4.78M	Buy	+40,000	New	+$4.74M	1.58%	28
2019 Q3	–	Sell	-30,000	Closed	-$1.95M	–	58
2019 Q2	$1.95M	Sell	30,000 -20,000	-40%	-$1.25M	0.47%	55
2019 Q1	$3.13M	Buy	+50,000	New	+$2.35M	1.15%	41
2018 Q3	–	Sell	-16,002	Closed	-$1M	–	69
2018 Q2	$1.28M	Sell	16,002 -18,998	-54%	-$1.58M	0.49%	57
2018 Q1	$3.03M	Buy	+35,000	New	+$2.83M	1.42%	30

Other funds holding NVRO

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FAM

Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

JSP

Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sivik Global Healthcare's NVRO Position: Q3 2020 in Review

Sivik Global Healthcare sold out of NEVRO CORP. (NVRO) in Q3 2020, closing a stake of 40,000 shares — an estimated $4.78M sold.

Sivik Global Healthcare first reported a position in NVRO in Q1 2018 and held it in 5 quarters. The position peaked at $4.78M in Q2 2020. 210 funds tracked by Wall St. Rank hold NVRO as of Q3 2020.

Sivik Global Healthcare reported no remaining NEVRO CORP. position as of Q3 2020 after selling out during the quarter.
Sivik Global Healthcare sold 40,000 NEVRO CORP. shares in Q3 2020, an estimated $4.78M.
Sivik Global Healthcare first reported a position in NEVRO CORP. in Q1 2018 and held it in 5 quarters.
Sivik Global Healthcare's NEVRO CORP. position peaked at $4.78M in Q2 2020.
210 funds tracked by Wall St. Rank held NEVRO CORP. as of Q3 2020.

Based on Sivik Global Healthcare's 13F filing for Q3 2020, filed 13 Nov 2020.